# Dual-Reference Source-Free Active Domain Adaptation for Nasopharyngeal Carcinoma Tumor Segmentation across Multiple Hospitals ğŸ¥

We are excited to announce that our paper was accepted for publication at **IEEE TMI 2024**! ğŸ¥³ğŸ¥³ğŸ¥³

This repository contains the official implementation of our paper. 
You can access the paper [here](https://ieeexplore.ieee.org/abstract/document/10553522).

## Introduction ğŸ“‘

This project introduces a new setting in medical image segmentation, termed **Source-Free Active Domain Adaptation (SFADA)**. SFADA aims to facilitate cross-center medical image segmentation while protecting data privacy and reducing the workload on medical professionals. By requiring only minimal labeling effort, SFADA achieves effective model transfer and results comparable to those of fully supervised approaches.

<img width="1546" alt="compa" src="https://github.com/whq-xxh/Active-GTV-Seg/assets/119860058/faea09fc-2437-434d-a332-356529a101ea">
Visual comparison of traditional training and our Source-Free Active Domain Adaptation (SFADA) training. Our approach safeguards the source data while demanding only a minimal annotation effort.


## How to Run the Code ğŸ› 

*We are currently preparing detailed instructions on how to set up and run the code. Please check back soon.*

## Dataset Information ğŸ“Š

*Details on how to access and use the dataset for this study are currently being organized. Please check back soon.*

## Citation ğŸ“–

If you find our work useful or relevant to your research, please consider citing:
```
@article{wang2024dual,
  title={Dual-Reference Source-Free Active Domain Adaptation for Nasopharyngeal Carcinoma Tumor Segmentation across Multiple Hospitals},
  author={Wang, Hongqiu and Chen, Jian and Zhang, Shichen and He, Yuan and Xu, Jinfeng and Wu, Mengwan and He, Jinlan and Liao, Wenjun and Luo, Xiangde},
  journal={IEEE Transactions on Medical Imaging},
  year={2024},
  publisher={IEEE}
}
```

## Comparison with Other Methods ğŸ“ˆ

*Details on other comparison approaches will be added soon.*
